News Articles

      • 8 March, 2019

    Sharing Excellent Science and Growing Personal Networks

    Each year our annual ISSCR meeting showcases for the world the potential of stem cell science and advances already underway that are changing the face of human healthcare. We highlight the latest innovative research and scientific developments that are propelling the field forward in a variety of ways. ISSCR 2019 in Los Angeles is a terrific opportunity to inspire us with research at the leading-edge of scientific discovery
    Full story
      • 25 February, 2019

    Progress in Stem Cell Science & Regenerative Medicine On Tap in Los Angeles, 26-29 June

    Top scientists and researchers from academia, medicine, and industry will gather to share groundbreaking stem cell science and its translation to clinical application at the annual meeting of the International Society for Stem Cell Research (ISSCR), 26-29 June in Los Angeles, Calif.
    Full story
      • 22 February, 2019

    Advocating for Science and Research

    Scientists play a critical role in advocating for research that is advancing healthcare and biomedicine. In the February edition of Stem Cell Reports, several ISSCR researchers share their answers to the question 'Why is it important to you to support fetal tissue research?'
    Full story
      • 8 February, 2019

    ISSCR Announces 2019 Award Recipients

    The ISSCR announces the recipients of its 2019 Award for Innovation, Dr. Susan Lim Award for Outstanding Young Investigator, Tobias Award Lecture, and Public Service Award. Awardees will be recognized at the ISSCR annual meeting, 26-29 June, in Los Angeles, Calif., U.S.
    Full story
      • 8 February, 2019

    New Voices, Breakthrough Science at ISSCR 2019

    If you’re an enterprising stem cell scientist with exciting work to publish this year, the ISSCR annual meeting in Los Angeles, 26-29 June, is the place to take the stage and showcase your science to colleagues and the field. We’ve developed a new program structure this year that dedicates 15 plenary speaking spots to abstract-selected speakers, to showcase the talents of the next generation of scientists.
    Full story
      • 21 January, 2019

    ISSCR Introduces Chief Operating Officer Keith Alm

    Keith Alm joined the ISSCR as chief operating officer in January 2019, after serving as a brand strategist and consultant for the society for nearly a decade. He’s worked with many of the organization's leaders on strategic positioning, communications, and partnerships.
    Full story
      • 4 January, 2019

    Standing Up for Scientific Research

    The ISSCR’s support for stem cell science and the field is central to our mission, and we speak up for policies around the world that allow our work to continue and thrive. We also provide background and current understanding about stem cell science to inform decision makers about key issues affecting science and health.
    Full story
      • 13 December, 2018

    ISSCR Testimony in U.S. Congress Regarding Need for Fetal Tissue Research

    In written and oral testimony before the U.S. House of Representatives Oversight and Government Reform Committee today, former ISSCR president Sally Temple describes fetal tissue research as essential in studying and developing therapies for cancer, HIV, Zika, tuberculous, and other devastating diseases.
    Full story
      • 5 December, 2018

    2018 ISSCR Year in Review

    Stem cell science and regenerative medicine has made great progress in 2018, with significant clinical trials underway in several research areas, and advances in understanding that are illuminating new research pathways. The role of the ISSCR in supporting the research and its responsible translation to the clinic has never been more important. I want to highlight for you some of ISSCR’s work throughout the year that I believe helps advance science, give voice to our members, and sustain this ever-evolving field.
    Full story
      • 26 November, 2018

    ISSCR Comments on Reports of Chinese Scientists Performing Genome-Editing During Fertility Treatment

    Reports indicate that scientists in China have used CRISPR-mediated genome editing during in vitro fertilization to modify the genetic material of two embryos that were subsequently implanted into a patient, leading to the birth of two babies. As ISSCR and a number of other organizations have previously stated, the use of nuclear genome editing technologies, such as CRISPR, during fertility treatment is premature and should not be attempted at this time.
    Full story
      • 21 November, 2018

    ISSCR Comments to FDA Regarding ClinicalTrials.gov

    In a letter to the U.S. Food and Drug Administration (FDA), the ISSCR commented on proposed industry guidance for "Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank."
    Full story
      • 16 November, 2018

    ISSCR Applauds FDA, FTC for Holding Deceptive Stem Cell Clinics Accountable

    The U.S. Food and Drug Administration has issued a warning letter to StemGenex of San Diego after an investigation found its cellular therapy does not conform with good manufacturing practice requirements, is being illegally marketed to treat conditions for which it has not been proven safe or effective, and is putting patients at risk.
    Full story
      • 16 November, 2018

    New Perspectives in Stem Cell Reports

    In this month's issue of the ISSCR journal, 2018 award recipients Graziella Pellegrini and Michele De Luca (Innovation Award), and Connie Eaves (Tobias Lecture), share perspectives on their science, and scientists write about the ethical challenges of premature delivery of stem cell-based therapies.
    Full story
      • 12 November, 2018

    Convergence of Stem Cell Science and Medicine

    Stem cell research is moving ever more deliberately toward the clinic with increasing momentum and is recognized as one of the most promising approaches for developing new kinds of medicines. The rapid advances in this field are having profound effects on how researchers conceive and pursue their work in traditional academic or research institutions and in commercial enterprises.
    Full story
      • 16 October, 2018

    ISSCR Letter to U.S. Department of Transportation re Transportation of Animals for Research

    The ISSCR writes in support of the National Association for Biomedical Research (NABR) complaint requesting relief from discriminatory airline carriage policies that impede the transportation of animals for biomedical research.
    Full story